Stocks cratered and bond yields hit their lowest level since October as investors flee risk assets and predict a hit to ...

Volatility has swept the market following tariff announcements, with many recalculating their growth outlooks under the new ...

VeChain (VET) drops 8% amid U.S. tariff news, tests $0.018 support despite rising activity and upcoming ecosystem overhaul.

Lives Lived: Joe DePugh was a gifted young baseball player when he gave his clumsy teammate Bruce Springsteen the nickname ...

As usual, the soft metrics tell a more complete story. Active customers increased by 5% to 2.67 million, and average orders ...

The Vanguard S&P 500 Growth ETF, specifically, has a strong chance of surviving market downturns. Companies within the S&P ...

The calendar may have flipped to April, but trade drama is still driving the markets. President Trump’s April 2 “Liberation ...

New data show that Canada’s inequality crisis is driven by both billionaire wealth and runaway housing costs. Without a ...

AbbVie ABBV stock has gained 16.1% so far this year compared with an increase of 4.0% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

As Trump’s trade war led stocks to post their worst first quarter since 2022, diversification proved its worth.

Generative AI represents the next paradigm shift—a fundamental transformation in how software companies approach growth.

Monitoring and interpreting these essential financial metrics can provide invaluable insights into the fiscal health and ...